{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:07:19Z","timestamp":1761293239104},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T00:00:00Z","timestamp":1424217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0424-1","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T11:48:24Z","timestamp":1424173704000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases"],"prefix":"10.1186","volume":"13","author":[{"given":"Fulvio","family":"Santacatterina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina N\u00fa\u00f1ez","family":"de Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M","family":"Cuezva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"S\u00e1nchez-Arag\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,18]]},"reference":[{"key":"424_CR1","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"424_CR2","first-page":"543","volume":"2011","author":"IM Willers","year":"1807","unstructured":"Willers IM, Cuezva JM. Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: A key regulator of the metabolic phenotype in cancer. Biochim Biophys Acta. 1807;2011:543\u201351.","journal-title":"Biochim Biophys Acta"},{"key":"424_CR3","first-page":"6674","volume":"62","author":"JM Cuezva","year":"2002","unstructured":"Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, et al. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 2002;62:6674\u201381.","journal-title":"Cancer Res"},{"key":"424_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.canlet.2011.07.022","volume":"311","author":"M Aldea","year":"2011","unstructured":"Aldea M, Clofent J, Nunez De Arenas C, Chamorro M, Velasco M, Berrendero JR, et al. Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer. Cancer Lett. 2011;311:210\u20138.","journal-title":"Cancer Lett"},{"key":"424_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1479-5876-9-19","volume":"9","author":"M Sanchez-Arago","year":"2011","unstructured":"Sanchez-Arago M, Cuezva JM. The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil. J Transl Med. 2011;9:19.","journal-title":"J Transl Med"},{"key":"424_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/ars.2012.4883","volume":"19","author":"M Sanchez-Arago","year":"2013","unstructured":"Sanchez-Arago M, Formentini L, Cuezva JM. Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors. Antioxid Redox Signal. 2013;19:285\u201398.","journal-title":"Antioxid Redox Signal"},{"key":"424_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molonc.2010.09.003","volume":"4","author":"C Mueller","year":"2010","unstructured":"Mueller C, Liotta LA, Espina V. Reverse phase protein microarrays advance to use in clinical trials. Mol Oncol. 2010;4:461\u201381.","journal-title":"Mol Oncol"},{"key":"424_CR8","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1158\/1535-7163.MCT-06-0334","volume":"5","author":"R Tibes","year":"2006","unstructured":"Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills GB, et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther. 2006;5:2512\u201321.","journal-title":"Mol Cancer Ther"},{"key":"424_CR9","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/nbt910","volume":"21","author":"GA Michaud","year":"2003","unstructured":"Michaud GA, Salcius M, Zhou F, Bangham R, Bonin J, Guo H, et al. Analyzing antibody specificity with whole proteome microarrays. Nat Biotechnol. 2003;21:1509\u201312.","journal-title":"Nat Biotechnol"},{"key":"424_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature02627","volume":"429","author":"RL Strausberg","year":"2004","unstructured":"Strausberg RL, Simpson AJ, Old LJ, Riggins GJ. Oncogenomics and the development of new cancer therapies. Nature. 2004;429:469\u201374.","journal-title":"Nature"},{"key":"424_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1593\/tlo.09106","volume":"2","author":"P Acebo","year":"2009","unstructured":"Acebo P, Giner D, Calvo P, Blanco-Rivero A, Ortega AD, Fernandez PL, et al. Cancer abolishes the tissue type-specific differences in the phenotype of energetic metabolism. Transl Oncol. 2009;2:138\u201345.","journal-title":"Transl Oncol"},{"key":"424_CR12","doi-asserted-by":"publisher","first-page":"25308","DOI":"10.1074\/jbc.M110.146480","volume":"285","author":"L Sanchez-Cenizo","year":"2010","unstructured":"Sanchez-Cenizo L, Formentini L, Aldea M, Ortega AD, Garcia-Huerta P, Sanchez-Arago M, et al. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H\u2009+\u2009\u2212ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J Biol Chem. 2010;285:25308\u201313.","journal-title":"J Biol Chem"},{"key":"424_CR13","first-page":"838","volume":"2012","author":"IM Willers","year":"1817","unstructured":"Willers IM, Mart\u00ednez-Reyes I, Mart\u00ednez-Diez M, Cuezva JM. miR-127-5p targets the 3'UTR of human \u03b2-F1-ATPase mRNA and inhibits its translation. Biochim Biophys Acta-Bioenergetics. 1817;2012:838\u201348.","journal-title":"Biochim Biophys Acta-Bioenergetics"},{"key":"424_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/35049567","volume":"1","author":"L Liotta","year":"2000","unstructured":"Liotta L, Petricoin E. Molecular profiling of human cancer. Nat Rev Genet. 2000;1:48\u201356.","journal-title":"Nat Rev Genet"},{"key":"424_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.celrep.2014.02.046","volume":"7","author":"WW Chen","year":"2014","unstructured":"Chen WW, Birsoy K, Mihaylova MM, Snitkin H, Stasinski I, Yucel B, et al. Inhibition of ATPIF1 ameliorates severe mitochondrial respiratory chain dysfunction in mammalian cells. Cell Rep. 2014;7:27\u201334.","journal-title":"Cell Rep"},{"key":"424_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","volume":"83","author":"A Lucia","year":"2012","unstructured":"Lucia A, Ruiz JR, Santalla A, Nogales-Gadea G, Rubio JC, Garcia-Consuegra I, et al. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry. 2012;83:322\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"424_CR17","doi-asserted-by":"publisher","first-page":"e31718","DOI":"10.1371\/journal.pone.0031718","volume":"7","author":"G Nogales-Gadea","year":"2012","unstructured":"Nogales-Gadea G, Consuegra-Garcia I, Rubio JC, Arenas J, Cuadros M, Camara Y, et al. A transcriptomic approach to search for novel phenotypic regulators in McArdle disease. PLoS One. 2012;7:e31718.","journal-title":"PLoS One"},{"key":"424_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10863-007-9087-9","volume":"39","author":"JM Cuezva","year":"2007","unstructured":"Cuezva JM, Sanchez-Arago M, Sala S, Blanco-Rivero A, Ortega AD. A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer. J Bioenerg Biomembr. 2007;39:259\u201365.","journal-title":"J Bioenerg Biomembr"},{"key":"424_CR19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.bbadis.2009.01.006","volume":"1792","author":"JM Cuezva","year":"2009","unstructured":"Cuezva JM, Ortega AD, Willers I, Sanchez-Cenizo L, Aldea M, Sanchez-Arago M. The tumor suppressor function of mitochondria: translation into the clinics. Biochim Biophys Acta. 2009;1792:1145\u201358.","journal-title":"Biochim Biophys Acta"},{"key":"424_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.biosystems.2006.07.014","volume":"88","author":"W Balzano","year":"2007","unstructured":"Balzano W, Del Sorbo MR. Genomic comparison using data mining techniques based on a possibilistic fuzzy sets model. Biosystems. 2007;88:343\u20139.","journal-title":"Biosystems"},{"key":"424_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1083\/jcb.201212142","volume":"201","author":"F Rahimov","year":"2013","unstructured":"Rahimov F, Kunkel LM. The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol. 2013;201:499\u2013510.","journal-title":"J Cell Biol"},{"key":"424_CR22","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"RJ Lemmers","year":"2012","unstructured":"Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet. 2012;44:1370\u20134.","journal-title":"Nat Genet"},{"key":"424_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ajhg.2012.07.009","volume":"91","author":"MC Manzini","year":"2012","unstructured":"Manzini MC, Tambunan DE, Hill RS, Yu TW, Maynard TM, Heinzen EL, et al. Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am J Hum Genet. 2012;91:541\u20137.","journal-title":"Am J Hum Genet"},{"key":"424_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/508158a","volume":"508","author":"H Ledford","year":"2014","unstructured":"Ledford H. Metabolic quirks yield tumour hope. Nature. 2014;508:158\u20139.","journal-title":"Nature"},{"issue":"24","key":"424_CR25","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1093\/hmg\/ddu366","volume":"23","author":"Y Hathout","year":"2014","unstructured":"Hathout Y, Marathi RL, Rayavarapu S, Zhang A, Brown KJ, Seol H, et al. Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients. Hum Mol Genet. 2014;23(24):6458\u201369.","journal-title":"Hum Mol Genet"},{"key":"424_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1515\/CCLM.2010.179","volume":"48","author":"P Brancaccio","year":"2010","unstructured":"Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clin Chem Lab Med. 2010;48:757\u201367.","journal-title":"Clin Chem Lab Med"},{"key":"424_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF00703210","volume":"59","author":"K Shima","year":"1983","unstructured":"Shima K, Tashiro K, Hibi N, Tsukada Y, Hirai H. Carbonic anhydrase-III immunohistochemical localization in human skeletal muscle. Acta Neuropathol. 1983;59:237\u20139.","journal-title":"Acta Neuropathol"},{"key":"424_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/bmj.317.7164.991","volume":"317","author":"AE Emery","year":"1998","unstructured":"Emery AE. The muscular dystrophies. BMJ. 1998;317:991\u20135.","journal-title":"BMJ"},{"key":"424_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1074\/jbc.M113.493270","volume":"289","author":"R Ramadasan-Nair","year":"2014","unstructured":"Ramadasan-Nair R, Gayathri N, Mishra S, Sunitha B, Mythri RB, Nalini A, et al. Mitochondrial alterations and oxidative stress in an acute transient mouse model of muscle degeneration: implications for muscular dystrophy and related muscle pathologies. J Biol Chem. 2014;289:485\u2013509.","journal-title":"J Biol Chem"},{"key":"424_CR30","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1021\/pr2001385","volume":"10","author":"L Guevel","year":"2011","unstructured":"Guevel L, Lavoie JR, Perez-Iratxeta C, Rouger K, Dubreil L, Feron M, et al. Quantitative proteomic analysis of dystrophic dog muscle. J Proteome Res. 2011;10:2465\u201378.","journal-title":"J Proteome Res"},{"key":"424_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/328434a0","volume":"328","author":"AH Burghes","year":"1987","unstructured":"Burghes AH, Logan C, Hu X, Belfall B, Worton RG, Ray PN. A cDNA clone from the Duchenne\/Becker muscular dystrophy gene. Nature. 1987;328:434\u20137.","journal-title":"Nature"},{"key":"424_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1432-1033.1994.tb18958.x","volume":"222","author":"M Yoshida","year":"1994","unstructured":"Yoshida M, Suzuki A, Yamamoto H, Noguchi S, Mizuno Y, Ozawa E. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem. 1994;222:1055\u201361.","journal-title":"Eur J Biochem"},{"key":"424_CR33","doi-asserted-by":"publisher","first-page":"16234","DOI":"10.1073\/pnas.1209508109","volume":"109","author":"F Rahimov","year":"2012","unstructured":"Rahimov F, King OD, Leung DG, Bibat GM, Emerson Jr CP, Kunkel LM, et al. Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proc Natl Acad Sci U S A. 2012;109:16234\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"424_CR34","first-page":"547","volume":"19","author":"P Doran","year":"2007","unstructured":"Doran P, Donoghue P, O'Connell K, Gannon J, Ohlendieck K. Proteomic profiling of pathological and aged skeletal muscle fibres by peptide mass fingerprinting (Review). Int J Mol Med. 2007;19:547\u201364.","journal-title":"Int J Mol Med"},{"key":"424_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.nmd.2011.05.011","volume":"21","author":"VD Nadarajah","year":"2011","unstructured":"Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, Lochmuller H, et al. Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord. 2011;21:569\u201378.","journal-title":"Neuromuscul Disord"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0424-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-015-0424-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0424-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0424-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:32:15Z","timestamp":1630571535000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-015-0424-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0424-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,18]]},"assertion":[{"value":"30 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"65"}}